Page 326 - Multidisipliner Covid 19

BÖLÜM 20

KAYNAKLAR

1. Chan JF, Yuan S, Kok KH, et al. A familialcluster of pneumoniaassoci-
atedwiththe 2019 novelcoronavirusindicatingperson-to-persontrans-
mission: a study of a familycluster. Lancet. 2020;395(10223):514-523.
doi:10.1016/S0140-6736(20)30154-9.
2. Huang C, Wang Y, Li X, et al. Clinicalfeatures of patientsinfectedwith
2019 novelcoronavirus in Wuhan, China[publishedcorrectionappears
in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497-506.
3. Singhal, T. 2020. “A Review of Coronavirus Disease-2019 (COVID-19).”,
TheIndianJournal of Pediatrics, 87, 281-286.
4. Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acuterespirator-
ysyndrome. N Engl J Med. 2003;349(25):2431-2441.
5. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novelcorona-
virus (2019-nCoV) byreal-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
6. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-
19, SARS and MERS: aretheycloselyrelated?.ClinMicrobiolInfect. 2020;
26(6):729-734. doi:10.1016/j.cmi.2020.03.026
7. de Wit E, vanDoremalen N, Falzarano D, Munster VJ. SARS and MERS:
recentinsightsintoemergingcoronaviruses. NatRevMicrobiol. 2016;14(8):
523-534.
8. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-convertingenzyme 2
is a functionalreceptorforthe SARS coronavirus. Nature. 2003;426(6965):
450-454.
9. Simmons G, Bertram S, Glowacka I, et al. Differenthostcellproteases-
activatethe SARS-coronavirusspike-protein forcell-cellandvirus-cellfu-
sion. Virology. 2011;413(2):265_274.
10. Sawicki SG, Sawicki DL. Coronavirustranscription: a perspective. Curr
Top MicrobiolImmunol. 2005;287:31_55.
11. Hussain S, Pan J, Chen Y, et al. Identification of novelsubgenomicRNAs-
andnoncanonicaltranscriptioninitiationsignals of severe acuterespira-
torysyndromecoronavirus. J Virol. 2005;79(9):5288_5295.
12. de Wilde AH, Snijder EJ, Kikkert M, vanHemert MJ. Host Factors in
Coronavirus Replication. Curr Top MicrobiolImmunol. 2018;419:1-42.
13. Groeneveld AB. Vascularpharmacology of acutelunginjuryandacuter-
espiratorydistresssyndrome. VasculPharmacol. 2002;39(4-5):247_256.
14. Rokni M, Ghasemi V, Tavakoli Z. Immuneresponsesandpathogenesis

325